Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Moleculin Biotech, Inc. (MBRX)
|
Add to portfolio |
|
|
|
| Price: |
$1.90
| | Metrics |
| OS: |
29.8
|
M
| |
|
|
| Market cap: |
$56.6
|
M
| |
|
|
|
Net cash:
|
$32.2
|
M
| |
$1.08
|
per share
|
|
EV:
|
$24.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($28.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | -33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | | | | | | | | 0.0 |
| Research and development | 19.0 | 14.4 | 12.8 | 11.0 | 9.7 | 4.5 | 1.5 | |
| General and administrative | 11.5 | 8.4 | 6.8 | 6.3 | 5.2 | 4.1 | 2.4 | 0.0 |
| EBIT | -28.2 | -23.0 | -19.7 | -17.5 | -15.0 | -8.7 | -3.9 | 0.0 |
| Pre-tax income | -29.0 | -15.9 | -17.4 | -13.4 | -11.9 | -9.8 | -3.9 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 1.7% | 0.0% | 0.0% | 0.0% | |
| Net income | -29.0 | -15.9 | -17.4 | -13.2 | -11.9 | -9.8 | -3.9 | 0.0 |
| |
| Diluted EPS | ($1.01) | ($0.59) | ($1.76) | ($1.95) | ($0.46) | ($0.53) | ($0.40) | |
| Shares outstanding (diluted) | 28.6 | 26.9 | 9.8 | 6.8 | 25.9 | 18.6 | 9.8 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|